Vincristine Sulfate

Spezifikationen

2068-78-2CAS-Nummer

218-190-0EG-Nummer

methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.01IUPAC-Name

C46H58N4O14SChemische Formel

923 g/molMolekulargewicht

Vincristine sulfate; 2068-78-2; Vincrisul; Onkovin; Vincristine sulphate; VCR sulfate; Kyocristine; Lilly 37231; Novopharm; Leurocristine sulfate; Vincristini sulfas; Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt); NSC 67574; Vincrex; Leurocristine, sulfate (1:1) (salt); Vincristine, sulfate; Leurocristine, sulfate; Vincasar PFS; NSC67574; Vincristine Sulfate PFS; Marqibo Kit; DTXSID8044331; LILLY-37231; Leurocristine sulfate (1:1) (salt); Vincasar; CHEBI:79401; Vincosid; PFS, Vincasar; Sulfate, Vincristine; RefChem:56476; DTXCID6024331; 22-OXOVINCALEUKOBLASTINE SULFATE (1:1) (SALT); 218-190-0; Methyl (3aR,4R,5S,5aR,10bR,13aR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-methoxycarbonyl-1,4,5,6,7,8,9,10-octahydro-3,7-methano-3-azacycloundecino(5,4-b)indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino(8,1-cd)carbazole-5-carboxylate monosulfate; T5IRO3534A; Oncovin; Vincaleukoblastine, 22-oxo-, sulfate (1:1); Marqibo; rel-Vincristine Sulfate; C46H58N4O14S; MFCD08706469; Vincristine (sulfate); 1217704-93-2; MLS002702994; Oncovin (Lilly); Vincasar (TN); Marqibo (TN); Oncovin (TN); Vincrex (TN); Vincristine sulphate Salt; Vincristine sulfate liposome; SCHEMBL3710; SCHEMBL3998; Leurocristine sulfate (1:1); CHEMBL501867; orb1309169; SCHEMBL29895946; HY-N0488R; Leurocristine (sulfate);NSC-67574 (sulfate);22-Oxovincaleukoblastine (sulfate); Vincristine (sulfate) (Standard); Vincristine sulfate (JP18/USP); HMS3414L13; HMS3678L11; MFCD27980578; 22-Oxovincaleukoblastine sulfate salt; AKOS015895862; EBC-609587; FV28696; NS00076429; V0129; V5254; LCR; VCR; D02197; Sulfuric acid--22-oxovincaleukoblastine (1/1); (2ALPHA,2'BETA,3ALPHA,4ALPHA,5BETA,19BETA)-22-OXOVINCALEUKOBLASTINE SULFATE (1:1); methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate; sulfuric acid; methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid; methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid; methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((3S,5S,7S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfateSynonyme